- Accueil
- Recherche
- Translational Radiopharmaceutical Sciences
- TRS Publications
TRS Publications
Identifying and navigating bottlenecks in the translation of novel radiopharmaceuticals: a perspective
Schottelius M.
Eur J Nucl Med Mol Imaging. 2025 Feb;52(3)
[99mTc]-PentixaTec SPECT/CT for Imaging of Chemokine Receptor 4 Expression After Myocardial Infarction.
Liebich A, Bundschuh RA, Pfob CH, Kircher M, Wienand G, Raake P, Nekolla SG, Schottelius M, Higuchi T, Rieger M, Lapa C.
Circ Cardiovasc Imaging. 2024 Nov;17(11)
C-X-C Motif Chemokine Receptor 4-Directed Scintigraphy Using [99mTc]Tc-Pentixatec in Primary Aldosteronism: A Proof-of-Concept Study
Enke JS, Ritzel K, Asbach E, Reitsam NG, Märkl B, Knösel T, Brüdgam D, Kircher M, Pfob CH, Bundschuh RA, Rinscheid A, Nittbaur B, Wienand G, Schottelius M, Reincke M, Lapa C, Dierks A.
J Nucl Med. 2024 Oct 1;65(10)
Antibody-peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins.
Petruzzella A, Bruand M, Santamaria-Martínez A, Katanayeva N, Reymond L, Wehrle S, Georgeon S, Inel D, van Dalen FJ, Viertl D, Lau K, Pojer F, Schottelius M, Zoete V, Verdoes M, Arber C, Correia BE, Oricchio E.
Nat Chem Biol. 2024 Sep 20
Preclinical SPECT and PET: Joint EANM and ESMI procedure guideline for implementing an efficient quality control programme
Vanhove C, Koole M, Fragoso Costa P, Schottelius M, Mannheim J, Kuntner C, Warnock G, McDougald W, Tavares A, Bernsen M.
Eur J Nucl Med Mol Imaging. 2024 Nov;51(13)
Lessons learned in application driven imaging agent design for image-guided surgery.
Buckle T, Rietbergen DDD, de Wit-van der Veen L, Schottelius M
Eur J Nucl Med Mol Imaging. 2024 Jun 20
Validation of a size exclusion method for concomitant purification and formulation of peptide radiopharmaceuticals.
Martin S, Wendlinger L, Litvinenko A, Faizova R, Schottelius M
EJNMMI Radiopharm Chem. 2024 Mar 21;9(1):23
Site-selective template-directed synthesis of antibody Fc conjugates with concomitant ligand release
Postupalenko V, Marx L, Pantin M, Viertl D, Gsponer N, Giudice G, Gasilova N, Schottelius M, Lévy F, Garrouste P, Segura JM, Nyanguile O.
Chem. Sci., 2024,15
Integration of DOTA as a bridging unit during solid-phase peptide synthesis
Lennard Wendlinger, Mara Parzinger, Margret Schottelius, Hans-Jürgen Wester
Volume 6, December 2023, 101076
[(99m)Tc]Tc-PentixaTec: development, extensive pre-clinical evaluation, and first human experience.
Konrad M, Rinscheid A, Wienand G, Nittbaur B, Wester HJ, Janzen T, Lapa C, Pfob CH, Schottelius M
Eur J Nucl Med Mol Imaging. 2023 Aug 19
Influence of corticosteroid treatment on CXCR4 expression in DLBCL.
Martin S, Viertl D, Janz A, Habringer S, Keller U, Schottelius M
EJNMMI Res. 2023 May 10;13(1):40
In Vivo Targeting of CXCR4-New Horizons.
Schottelius M, Herrmann K, Lapa C
Cancers (Basel). 2021 Nov 25;13(23)
The role of fluorescent and hybrid tracers in radioguided surgery in urogenital malignancies.
de Vries HM, Schottelius M, Brouwer OR, Buckle T
Q J Nucl Med Mol Imaging. 2021 May 31
Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617.
Martin S, Tönnesmann R, Hierlmeier I, Maus S, Rosar F, Ruf J, Holland JP, Ezziddin S, Bartholomä MD
J Med Chem. 2021 Apr 7
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors.
Trotta AM, Aurilio M, D'Alterio C, Ieranò C, Di Martino D, Barbieri A, Luciano A, Gaballo P, Santagata S, Portella L, Tomassi S, Marinelli L, Sementa D, Novellino E, Lastoria S, Scala S, Schottelius M, Di Maro S
J Med Chem. 2021 Mar 25;64(6):3449-3461
Proof-of-Concept Study of the NOTI Chelating Platform: Preclinical Evaluation of 64Cu-Labeled Mono- and Trimeric c(RGDfK) Conjugates.
Martin S, Maus S, Stemler T, Rosar F, Khreish F, Holland JP, Ezziddin S, Bartholomä MD
Mol Imaging Biol. 2021 Feb;23(1):95-108
At the bench: Pre-clinical evidence for multiple functions of CXCR4 in cancer.
Luker GD, Yang J, Richmond A, Scala S, Festuccia C, Schottelius M, Wester HJ, Zimmermann J
J Leukoc Biol. 2020 Oct 26
A new class of PentixaFor- and PentixaTher-based theranostic agents with enhanced CXCR4-targeting efficiency.
Osl T, Schmidt A, Schwaiger M, Schottelius M, Wester HJ
Theranostics. 2020;10(18):8264-8280
[99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
P. Werner, C. Neumann, M. Eiber, H. J. Wester & M. Schottelius
EJNMMI Research. 2020 May; Volume 10, Article number: 45
From Theranostics to Immunotheranostics: the Concept
Niklaus Schaefer, John O. Prior & Margret Schottelius
54, pages 81–85(2020)
"Luke! Luke! Don't! It's a trap!"-spotlight on bias in animal experiments in nuclear oncology.
Nonnekens J, Schottelius M
Eur J Nucl Med Mol Imaging. 2020 May;47(5):1024-1026
CHUV
Rue du Bugnon 46
CH-1011 Lausanne, Vaud, Suisse
+41 21 314 1111
CHUV
Rue du Bugnon 46
CH-1011 Lausanne, Vaud, Suisse
+41 21 314 1111